Sign in
4

Changes in Ownership

RELMADA THERAPEUTICS, INC. Filed Acc 0001213900-19-026862

Options or other derivatives

  • CFO acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ence Chuck · CFO

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-19 Grant or award : show line 1 in the form Options to purchase common stock +60,000 $43.47 $2,608,200 60,000 D
Loading xslF345X03/ownership.xml…